Table 2

Radiographic indicators and baseline disease characteristics

RRR-achieved (N=33)RRR-failed (N=16)p (probability >χ2)
 Disease duration (years)4.7 (0.5–14.0)8.6 (0.5–25.0)0.0280
 DAS28 (ESR) score5.5 (1.9–7.6)5.7 (4.2–6.8)0.6976
 HAQ-DI1.0 (0.0–2.3)1.1 (0.0–1.8)0.6271
 mTSS46.9 (1.0–216.5)97.2 (6.0–314.0)0.0207
 Bone erosion score23.7 (0.0–127.5)55.5 (1.5–192.5)0.0119
 Joint space narrowing score23.2 (1.0–89.0)41.6 (4.5–121.5)0.0621
 Yearly progression of mTSS13.1 (0.8–51.3)15.0 (1.0–47.8)0.5794
 Yearly progression of mTSS1.0 (−2.9 to 10.5)0.7 (−2.0 to 6.7)0.5788
Primary end point
 Yearly progression of mTSS0.3 (−3.6 to 8.5)1.6 (–3.6 to 7.0)0.1087
 Median of yearly progression of mTSS0.01.5
 Yearly progression of mTSS <0.5 (%)67440.2161
  • Data are number of patients (%) for categorical data and the means for continuous data. Statistical difference was assessed by non-parametric Wilcoxon t test and p (probability >χ2) values were shown. Values in italic indicate a significant difference (p<0.05).

  • DAS28, Disease Activity Score based on assessments of 28 tender and 28 swollen joints; ESR, erythrocyte sedimentation rate; HAQ-DI, Health Assessment Questionnaire-Disability Index; mTSS, modified total Sharp score; RRR, remission induction by Remicade in rheumatoid arthritis.